BD (Becton, Dickinson and Company), a global medical technology company, announced that Peter Menziuso has been named executive vice president and president, BD Interventional, effective June 1.

Mr. Menziuso spent more than 30 years at Johnson & Johnson, where he most recently served as Company Group Chairman of Johnson & Johnson Vision. At J&J, he led a $5 billion global business with responsibility for commercial operations, research and development, supply chain, quality, finance and medical affairs.

According to BD, throughout his career, Mr. Menziuso has been recognized for strengthening market leadership, building high-performing teams and translating strategy into sustained performance through commercial rigor and operational excellence. 

“BD Interventional has a strong track record of performance, and Peter is the right leader to build on that momentum and continue delivering results,” said Tom Polen, chairman, CEO and president of BD. “Peter brings a strong combination of strategic leadership and operational discipline. He is grounded in delivering for customers and patients, building strong teams and driving consistent performance, positioning the business for sustained growth and continued strength across the portfolio.”

In his new role, Mr. Menziuso will oversee BD’s Interventional segment, which develops innovative technologies focused on advancing the treatment of peripheral vascular disease, cancer, urological and critical care conditions, and hernias.